ESR1 and triple-negative breast carcinoma: This issue is augmented with triple-negative breast cancer (TNBC), which is characterized by the lack of expression of the estrogen receptor (ER) and progesterone receptor (PR), and lack of the overexpression of the epidermal growth factor receptor 2 (HER2).